logo

For the Inventor, By the Inventor

Beverly, MA, United States of America

Akston Biosciences Corporation


USPTO Granted Patents = 22



Trademarks = 2

Forward Citations = 117

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Todd C Zion (22 out of 49 patents)

silverMedal Thomas M Lancaster (22 out of 49 patents)

bronzeMedal Thillainayagam Sathiyaseelan (4 out of 5 patents)

4.  Sylaja Murikipudi (2 out of 3 patents)

5.  Kexin Huang (2 out of 6 patents)


22 patents:

1. 12742000 - INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER (2026-09-22),
2. 12686709 - PD-L1 ANALOG FUSION PROTEINS FOR ANTIGEN SPECIFIC IMMUNOTHERAPY AND METHODS OF USE (2026-07-21),
3. 12454565 - PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use (2025-10-28),
4. 12195511 - Ultra-long acting insulin-Fc fusion protein (2025-01-14),
5. 11919935 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2024-03-05),
6. 11814418 - Ultra-long acting insulin-Fc fusion protein and methods of use (2023-11-14),
7. 11773151 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2023-10-03),
8. 11707517 - Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use (2023-07-25),
9. 11673934 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2023-06-13),
10. 11667689 - Insulin-Fc fusion proteins and methods of use to treat cancer (2023-06-06),
11. 11555058 - Cells engineered to express ultra-long acting insulin-Fc fusion proteins (2023-01-17),
12. 11359001 - Insulin-Fc fusions and methods of use (2022-06-14),
13. 11352407 - Ultra-long acting insulin-Fc fusion proteins (2022-06-07),
14. 11267862 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2022-03-08),
15. 11261229 - Ultra-long acting insulin-Fc fusion proteins and methods of use (2022-03-01),
Company Overview
Akston Biosciences Corporation, based in Beverly, MA, specializes in the development of innovative biopharmaceuticals. The company focuses on creating novel protein-based therapeutics and vaccines, leveraging advanced technologies in immunology and protein engineering. Its research aims to address significant unmet medical needs, particularly in the fields of infectious diseases and oncology. By harnessing its proprietary platforms, Akston is committed to advancing healthcare solutions that improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#12 in Beverly, MA

#906 in Massachusetts

#15,037 in US

#28,782 in the World

Beverly, MA (US)
Beverly, MA, United States of America

Akston Biosciences Corporation

Forward Citations = 117

5 inventors:

goldMedal Todd C Zion (22 out of 49 patents)

silverMedal Thomas M Lancaster (22 out of 49 patents)

bronzeMedal Thillainayagam Sathiyaseelan (4 out of 5 patents)

4.  Sylaja Murikipudi (2 out of 3 patents)

5.  Kexin Huang (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akston Biosciences Corporation. Retrieved from https://idiyas.com/company/akston-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…